Implement the results of its own research and development work, with a view to introducing a new product to the offer of P.P. Margomed Stanislaw Margol. (Q104274): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Created claim: summary (P836): The project concerns the implementation of the results of the research and development work carried out by the Applicant on the operational activities of the company. As a result, the offer by P.P. Margomed will be supplemented by a new product — a partially injection syringe with the trade name ProInject, with a comprehensive offer in the size of the syringes. The product developed is characterised by innovative solutions which determine its un...) |
||
| Property / summary | |||
The project concerns the implementation of the results of the research and development work carried out by the Applicant on the operational activities of the company. As a result, the offer by P.P. Margomed will be supplemented by a new product — a partially injection syringe with the trade name ProInject, with a comprehensive offer in the size of the syringes. The product developed is characterised by innovative solutions which determine its unique performance which gives an advantage over competing products. The production of this product will be possible following the implementation of a material and financial schedule, to the extent described in section D of the application for funding. The implementation of the investment is linked to measurable economic benefits: there will be an improvement in the competitive position of the company on the domestic market, including an increase in the market share of single use medicinal products, the launch of export sales to two new foreign markets and the systematic improvement of the competitive position in the markets concerned, an increase in the company’s level of product and technology innovation, an increase in the company’s employment, including highly skilled employees, the removal of the cost of loss of profits at present resulting from the under-utilisation of selected machinery and equipment. The project plans to use modern information and communication technologies and to engage with the scientific unit in order to ensure the smooth start of the production process and its rapid optimisation. The sales of the new product will be based on good distribution channels — cooperation with wholesalers of medical devices, including the expansion of trade with the company’s current permanent customers (see letters of intent attached to the proposal). (English) | |||
| Property / summary: The project concerns the implementation of the results of the research and development work carried out by the Applicant on the operational activities of the company. As a result, the offer by P.P. Margomed will be supplemented by a new product — a partially injection syringe with the trade name ProInject, with a comprehensive offer in the size of the syringes. The product developed is characterised by innovative solutions which determine its unique performance which gives an advantage over competing products. The production of this product will be possible following the implementation of a material and financial schedule, to the extent described in section D of the application for funding. The implementation of the investment is linked to measurable economic benefits: there will be an improvement in the competitive position of the company on the domestic market, including an increase in the market share of single use medicinal products, the launch of export sales to two new foreign markets and the systematic improvement of the competitive position in the markets concerned, an increase in the company’s level of product and technology innovation, an increase in the company’s employment, including highly skilled employees, the removal of the cost of loss of profits at present resulting from the under-utilisation of selected machinery and equipment. The project plans to use modern information and communication technologies and to engage with the scientific unit in order to ensure the smooth start of the production process and its rapid optimisation. The sales of the new product will be based on good distribution channels — cooperation with wholesalers of medical devices, including the expansion of trade with the company’s current permanent customers (see letters of intent attached to the proposal). (English) / rank | |||
Normal rank | |||
Revision as of 09:15, 9 March 2020
Project in Poland financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Implement the results of its own research and development work, with a view to introducing a new product to the offer of P.P. Margomed Stanislaw Margol. |
Project in Poland financed by DG Regio |
Statements
3,000,000.0 zloty
0 references
7,380,000.0 zloty
0 references
50.0 percent
0 references
1 December 2017
0 references
31 December 2019
0 references
PRZEDSIĘBIORSTWO PRODUKCYJNE MARGOMED STANISŁAW MARGOL
0 references
Projekt dotyczy wdrożenia wyników prac badawczo - rozwojowych, które zostały przeprowadzone przez Wnioskodawcę, do działalności operacyjnej przedsiębiorstwa. W efekcie oferta P.P. Margomed zostanie uzupełniona o nowy produkt - trzyczęściową strzykawkę do iniekcji o nazwie handlowej ProInject, stając się ofertą kompleksową w wymiarze strzykawek jednorazowych. Opracowany produkt charakteryzują innowacyjne rozwiązania, które decydują o jego unikalnych parametrach użytkowych, dających przewagę nad produktami konkurencyjnymi. Uruchomienie produkcji ww. wyrobu będzie możliwe w następstwie realizacji harmonogramu rzeczowo - finansowego, w zakresie opisanym w dziale D wniosku o dofinansowanie. Wdrożenie przedmiotowej inwestycji wiąże się z wymiernymi korzyściami ekonomicznymi: nastąpi poprawa pozycji konkurencyjnej przedsiębiorstwa na rynku krajowym, w tym powiększenie udziału w rynku produktów medycznych jednorazowego użytku, rozpoczęcie sprzedaży eksportowej na dwa nowe rynki zagraniczne i systematyczna poprawa pozycji konkurencyjnej na ww. rynkach, podniesienie poziomu innowacyjności przedsiębiorstwa w wymiarze produktowym i technologicznym, wzrost zatrudnienia w przedsiębiorstwie, w tym o kadrę wysokowykwalifikowaną, wyeliminowanie ponoszonych obecnie kosztów utraconych korzyści wynikających z niepełnego wykorzystania wybranych maszyn i urządzeń. W ramach projektu planuje się wykorzystanie nowoczesnych technologii informacyjno-komunikacyjnych oraz nawiązanie współpracy z jednostką naukową w celu zapewnienia sprawnego uruchomienia procesu produkcji i jego szybką optymalizację. Sprzedaż nowego produktu zostanie oparta na sprawdzonych kanałach dystrybucji - współpraca z hurtowniami wyrobów medycznych, w tym nastąpi rozszerzenie wymiany handlowej z obecnymi, stałymi klientami przedsiębiorstwa (patrz załączone do wniosku listy intencyjne). (Polish)
0 references
The project concerns the implementation of the results of the research and development work carried out by the Applicant on the operational activities of the company. As a result, the offer by P.P. Margomed will be supplemented by a new product — a partially injection syringe with the trade name ProInject, with a comprehensive offer in the size of the syringes. The product developed is characterised by innovative solutions which determine its unique performance which gives an advantage over competing products. The production of this product will be possible following the implementation of a material and financial schedule, to the extent described in section D of the application for funding. The implementation of the investment is linked to measurable economic benefits: there will be an improvement in the competitive position of the company on the domestic market, including an increase in the market share of single use medicinal products, the launch of export sales to two new foreign markets and the systematic improvement of the competitive position in the markets concerned, an increase in the company’s level of product and technology innovation, an increase in the company’s employment, including highly skilled employees, the removal of the cost of loss of profits at present resulting from the under-utilisation of selected machinery and equipment. The project plans to use modern information and communication technologies and to engage with the scientific unit in order to ensure the smooth start of the production process and its rapid optimisation. The sales of the new product will be based on good distribution channels — cooperation with wholesalers of medical devices, including the expansion of trade with the company’s current permanent customers (see letters of intent attached to the proposal). (English)
0 references
Identifiers
RPLU.03.07.00-06-0012/17
0 references